
  
    
      
        Background_NNP
        Chlamydiae_NNP are_VBP obligate_NN intracellular_NN pathogens_NNS that_WDT
        infect_NN a_DT variety_NN of_IN host_NN organisms_NNS and_CC exhibit_VB individual_JJ
        tissue_NN tropisms_NNS within_IN a_DT host_NN species_NNS ._. The_DT availability_NN of_IN
        complete_JJ genomic_JJ sequences_NNS for_IN different_JJ species_NNS has_VBZ
        provided_VBN a_DT contemporary_JJ impetus_NN for_IN research_NN to_TO uncover_VB
        specific_JJ relationships_NNS of_IN chlamydial_NN genes_NNS with_IN the_DT disease_NN
        process_NN ,_, an_DT impetus_NN that_WDT is_VBZ particularly_RB welcome_JJ because_IN
        the_DT fastidious_JJ growth_NN requirements_NNS of_IN the_DT organism_NN have_VBP
        made_VBN it_PRP relatively_RB intractable_JJ to_TO experimentation_NN ._. A_DT number_NN
        of_IN analyses_NNS dealing_VBG with_IN the_DT comparative_JJ genomics_NNS of_IN the_DT
        chlamydiae_NN have_VBP appeared_VBN in_IN the_DT recent_JJ literature_NN [_NN 1_CD ,_, 2_CD ,_,
        3_CD ]_NN ._.
        Chlamydiae_NNP all_DT progress_NN through_IN a_DT life_NN cycle_NN that_WDT is_VBZ
        intimately_RB tied_VBN to_TO success_NN as_IN a_DT pathogen_NN ._. The_DT host_NN is_VBZ
        invaded_VBD by_IN elementary_JJ bodies_NNS (_( EBs_NNP )_) ,_, which_WDT represent_VBP the_DT
        extracellular_NN infectious_JJ stage_NN ._. The_DT newly_RB established_VBN EBs_NNP
        develop_VB into_IN intracellular_NN reticulate_NN bodies_NNS (_( RBs_NNP )_) that_WDT
        replicate_VB in_IN anticipation_NN of_IN maturation_NN to_TO EBs_NNP ,_, which_WDT then_RB
        lyse_NN the_DT host_NN cell_NN and_CC initiate_VB a_DT new_JJ round_NN of_IN pathogen_NN
        proliferation_NN ._. Aggressive_NNP progress_NN through_IN repetitions_NNS of_IN
        this_DT cycle_NN characterizes_VBZ the_DT acute_JJ disease_NN process_NN ._.
        Distinct_NNP changes_NNS in_IN cell_NN size_NN ,_, chromatin_NN organization_NN ,_,
        membrane_NN characteristics_NNS and_CC metabolic_JJ competence_NN
        constitute_VBP endpoints_NNS of_IN a_DT reversible_JJ developmental_NN profile_NN ._.
        A_DT third_JJ metabolic_JJ stage_NN called_VBD persistence_NN is_VBZ increasingly_RB
        recognized_VBN to_TO attend_VB the_DT chronic_JJ disease_NN process_NN [_NN 4_CD ]_NN ._. The_DT
        persistent_JJ state_NN can_MD be_VB induced_VBN 
        in_IN vitro_NN in_IN tissue_NN culture_NN in_IN
        response_NN to_TO various_JJ environmental_JJ cues_NNS such_JJ as_IN nutrient_NN
        limitation_NN ,_, antibiotic_JJ treatment_NN or_CC presence_NN of_IN
        interferon-γ_JJ (_( IFN-γ_NNP )_) [_NN 5_CD ,_, 6_CD ]_NN ._. All_DT of_IN the_DT latter_JJ may_MD act_VB to_TO
        trigger_VB persistence_NN by_IN eliciting_VBG a_DT degree_NN of_IN metabolic_JJ
        starvation_NN [_NN 7_CD ]_NN ._. In_IN fact_NN ,_, it_PRP has_VBZ been_VBN shown_VBN [_NN 7_CD ]_NN that_IN even_RB
        normal_JJ blood_NN plasma_NN concentrations_NNS of_IN amino_JJ acids_NNS are_VBP
        sufficiently_RB limiting_VBG to_TO infected_JJ cell_NN cultures_NNS to_TO promote_VB
        the_DT persistent_JJ state_NN ._. Cells_NNP present_JJ in_IN the_DT persistent_JJ state_NN
        have_VBP been_VBN detected_VBN 
        in_IN vivo_NN ,_, for_IN example_NN ,_, in_IN the_DT synovial_NN
        membranes_NNS of_IN patients_NNS with_IN Chlamydia-associated_NNP reactive_JJ
        arthritis_NN [_NN 8_CD ]_NN ._. Chlamydial_NNP cells_NNS poised_VBN in_IN this_DT state_NN of_IN
        metabolic_JJ latency_NN exist_VB as_IN viable_JJ but_CC non-cultivable_JJ cells_NNS
        that_WDT are_VBP '_POS abnormally_RB '_POS enlarged_JJ and_CC which_WDT exhibit_NN
        distinctive_JJ morphological_JJ characteristics_NNS [_NN 4_CD ]_NN ._.
        One_CD of_IN the_DT most_RBS prominent_JJ host_NN protective_JJ responses_NNS to_TO
        chlamydial_NN infections_NNS has_VBZ been_VBN the_DT production_NN of_IN the_DT
        T-_NNP cell-derived_JJ pro-inflammatory_JJ cytokine_NN IFN-γ_NNP ._. This_DT
        cytokine_NN induces_VBZ a_DT variety_NN of_IN biochemical_JJ changes_NNS in_IN host_NN
        metabolism_NN ,_, apparently_RB designed_VBN to_TO thwart_VB the_DT ability_NN of_IN
        intracellular_NN parasites_NNS to_TO gain_VB access_NN to_TO host_VB resources_NNS ._.
        Relative_NNP sensitivity_NN to_TO IFN-γ_NNP varies_VBZ ,_, with_IN 
        C_NNP ._. muridarum_NN and_CC 
        C_NNP ._. psittaci_NN being_VBG relatively_RB
        resistant_JJ compared_VBN to_TO 
        C_NNP ._. pneumoniae_NN and_CC the_DT various_JJ 
        C_NNP ._. trachomatis_NNS serovars_NNS ._. The_DT relative_JJ
        insensitivity_NN 
        in_IN vivo_NN of_IN 
        C_NNP ._. muridarum_NN ,_, compared_VBN to_TO human_JJ
        strains_NNS of_IN 
        C_NNP ._. trachomatis_NNS ,_, is_VBZ supported_VBN by_IN the_DT
        results_NNS of_IN Cotter_NNP 
        et_CC al_NN ._. [_NN 9_CD ]_NN and_CC Perry_NNP 
        et_CC al_NN ._. [_NN 10_CD ]_NN ._. Conflicts_NNP in_IN the_DT
        literature_NN about_IN the_DT sensitivities_NNS of_IN 
        C_NNP ._. trachomatis_NNS and_CC 
        C_NNP ._. muridarum_NN isolates_VBZ to_TO
        IFN-γ-mediated_NNP inhibition_NN have_VBP been_VBN attributed_VBN to_TO strain_VB
        variation_NN [_NN 10_CD ]_NN ._. A_DT well_RB documented_VBN effect_NN of_IN IFN-γ_NNP has_VBZ been_VBN
        its_PRP$ ability_NN to_TO decrease_VB the_DT availability_NN of_IN L-_NNP tryptophan_NN in_IN
        host_NN cells_NNS ._. (_( Other_JJ anti-chlamydial_JJ effects_NNS involve_VBP the_DT
        inducible_JJ synthesis_NN of_IN nitric_JJ oxide_NN and_CC deprivation_NN of_IN iron_NN
        [_NN 11_CD ]_NN ._. )_) Although_IN effective_JJ L-_NNP tryptophan_NN starvation_NN may_MD
        resolve_VB an_DT acute_JJ infection_NN ,_, a_DT more_RBR modulated_JJ degree_NN of_IN
        starvation_NN for_IN L-_NNP tryptophan_NN is_VBZ thought_VBN to_TO be_VB intimately_RB
        involved_VBN in_IN the_DT phenomenon_NN of_IN persistence_NN [_NN 12_CD ]_NN ._. Thus_RB ,_,
        tryptophan_NN limitation_NN is_VBZ increasingly_RB recognized_VBN as_IN an_DT
        important_JJ factor_NN in_IN a_DT variety_NN of_IN chronic_JJ disease_NN
        conditions_NNS ._. As_IN initially_RB shown_VBN by_IN Byrne_NNP 
        et_CC al_NN ._. [_NN 13_CD ,_, 14_CD ]_NN and_CC confirmed_VBN by_IN
        others_NNS [_NN 15_CD ,_, 16_CD ]_NN ,_, IFN-γ_NNP acts_NNS by_IN inducing_VBG indoleamine_NN
        2_CD ,_, 3_CD -_: dioxygenase_NN ,_, a_DT host_NN enzyme_NN that_WDT converts_VBZ L-_NNP tryptophan_NN
        to_TO L-_NNP formylkynurenine_NN ._. (_( This_DT broad-specificity_JJ monomeric_JJ
        enzyme_NN is_VBZ different_JJ from_IN the_DT non-homologous_JJ tryptophan_NN
        2_CD ,_, 3_CD -_: dioxygenase_NN in_IN liver_NN [_NN 17_CD ]_NN and_CC brain_NN tissues_NNS [_NN 18_CD ]_NN ._. )_) In_IN
        addition_NN ,_, IFN-γ_NNP is_VBZ a_DT potent_JJ inducer_NN of_IN host_NN
        tryptophanyl-t_JJ RNA_NNP synthetase_NN [_NN 19_CD ]_NN ._. Thus_RB ,_, the_DT host_NN not_RB only_RB
        decreases_VBZ the_DT pool_NN of_IN tryptophan_NN available_JJ to_TO intracellular_NN
        parasites_NNS ,_, but_CC the_DT remaining_VBG tryptophan_NN molecules_NNS tend_VBP to_TO
        be_VB increasingly_RB sequestered_VBN by_IN the_DT elevated_VBD level_NN of_IN host_NN
        tryptophanyl-t_JJ RNA_NNP synthetase_NN ._.
        The_DT biological_JJ relationship_NN of_IN IFN-γ_NNP ,_, indoleamine_NN
        dioxygenase_NN ,_, tryptophan_NN limitation_NN and_CC the_DT persistent_JJ state_NN
        of_IN intracellular_NN parasitism_NN extends_VBZ beyond_IN chlamydial_NN
        parasites_NNS ,_, as_IN illustrated_VBN by_IN consideration_NN of_IN 
        Toxoplasma_NNP gondii_NN [_NN 20_CD ]_NN ._. This_DT
        unicellular_NN protozoan_NN is_VBZ a_DT eukaryotic_JJ intracellular_NN
        parasite_NN that_WDT is_VBZ subject_JJ to_TO tryptophan_NN limitation_NN by_IN
        exactly_RB the_DT same_JJ host_NN mechanism_NN used_VBN against_IN the_DT
        chlamydiae_NN ._. The_DT result_NN is_VBZ a_DT generally_RB widespread_JJ and_CC
        asymptomatic_JJ state_NN of_IN chronic_JJ infection_NN ._. Even_RB extracellular_NN
        bacteria_NNS such_JJ as_IN group_NN B_NNP streptococci_NN (_( tryptophan_NN
        auxotrophs_NNS )_) are_VBP inhibited_VBD by_IN the_DT IFN-γ_NNP mechanism_NN of_IN
        tryptophan_NN limitation_NN [_NN 21_CD ]_NN ._. In_IN this_DT context_NN ,_, it_PRP may_MD be_VB no_DT
        accident_NN that_WDT pathogens_NNS such_JJ as_IN 
        Enterococcus_NNP faecalis_NNS ,_, Haemophilus_NNP
        ducreyi_NN ,_, Clostridium_NNP difficile_NN and_CC 
        Cl_NNP ._. perfringens_NNS are_VBP conspicuous_JJ
        tryptophan_NN auxotrophs_NNS that_WDT maintain_VBP full_JJ competence_NN for_IN
        phenylalanine_NN and_CC tyrosine_NN biosynthesis_NNS ._. The_DT broad_JJ
        biological_JJ impact_NN of_IN host_NN tryptophan_NN catabolism_NN is_VBZ further_RBR
        illustrated_VBN by_IN the_DT hypothesis_NNS that_WDT tryptophan_NN catabolism_NN
        localized_JJ in_IN placental_NN tissue_NN provides_VBZ a_DT mechanism_NN
        (_( suppression_NN of_IN lymphocyte_NN proliferation_NN [_NN 22_CD ]_NN )_) to_TO prevent_VB
        immune_JJ rejection_NN of_IN the_DT mammalian_JJ fetus_NN [_NN 23_CD ]_NN ._. An_DT
        additional_JJ example_NN of_IN the_DT far-reaching_JJ consequences_NNS of_IN host_NN
        tryptophan_NN catabolism_NN is_VBZ illustrated_VBN by_IN the_DT potential_NN for_IN
        persistent_JJ immune_JJ activation_NN to_TO disrupt_VB the_DT balance_NN between_IN
        serotonin_NN and_CC kynurenine_NN production_NN from_IN tryptophan_NN ,_, thus_RB
        linking_VBG the_DT immunological_JJ network_NN and_CC neuropsychiatric_JJ
        consequences_NNS of_IN serotonin_NN imbalance_NN [_NN 24_CD ]_NN ._.
      
      
        Results_NNS and_CC discussion_NN
        
          Dynamic_NNP gene_NN reorganization_NN and_CC gene_NN flux_NN within_IN
          the_DT chlamydial_NN plasticity_NN zones_NNS
          Figure_NN 1_CD shows_VBZ the_DT gene_NN organization_NN in_IN 
          C_NNP ._. psittaci_NN of_IN tryptophan-pathway_JJ
          genes_NNS (_( 
          trp_NN )_) ,_, the_DT large_JJ toxin_NN gene_NN 
          lifA_NN ,_, a_DT perforin-family_JJ gene_NN ,_, and_CC a_DT
          conserved_JJ hypothetical_JJ gene_NN that_WDT is_VBZ specific_JJ to_TO the_DT 
          C_NNP ._. pneumoniae_NN /_NN C_NNP ._. psittaci_NN lineage_NN ._. 
          lifA_NN ,_, the_DT 
          trp_NN genes_NNS ,_, the_DT perforin-encoding_JJ
          gene_NN and_CC a_DT few_JJ other_JJ genes_NNS can_MD be_VB generally_RB recognized_VBN as_IN
          interspecies_NNS residents_NNS of_IN a_NNP '_POS plasticity_NN zone_NN '_'' located_VBN
          near_IN the_DT terminus_JJ of_IN replication_NN [_NN 2_CD ]_NN ._. As_IN Read_NNP 
          et_CC al_NN ._. [_NN 2_CD ]_NN pointed_VBD out_IN ,_, dynamic_JJ
          events_NNS of_IN gene_NN shuffling_NN ,_, gene_NN insertion_NN and_CC gene_NN loss_NN
          are_VBP apparent_JJ within_IN this_DT plasticity_NN zone_NN ._. They_PRP discussed_VBD
          the_DT lack_NN of_IN variation_NN in_IN GC_NNP content_NN and_CC the_DT absence_NN of_IN
          evidence_NN for_IN gene_NN transfer_NN ,_, as_RB well_RB as_IN the_DT variation_NN of_IN
          tryptophan-pathway_JJ genes_NNS ._.
          Substantial_NNP variation_NN is_VBZ also_RB striking_JJ with_IN respect_NN to_TO
          
          lifA_NN ._. C_NNP ._. psittaci_NN possesses_VBZ a_DT
          single_JJ copy_NN of_IN 
          lifA_NN ,_, C_NNP ._. muridarum_NN has_VBZ three_CD
          paralog_NN copies_NNS ,_, 
          C_NNP ._. trachomatis_NNS has_VBZ a_DT single_JJ
          pseudogene_NN with_IN frameshift_NN mutations_NNS and_CC 
          C_NNP ._. pneumoniae_NN lacks_VBZ 
          lifA_NN altogether_RB ._. 
          lifA_NN (_( lymphocyte_NN inhibitory_NN factor_NN )_)
          encodes_NNS a_DT large_JJ toxin_NN that_WDT can_MD block_VB production_NN of_IN IFN-γ_NNP ._.
          It_PRP therefore_RB undermines_NNS the_DT host_NN 's_POS ability_NN to_TO deplete_VB
          tryptophan_NN through_IN induction_NN of_IN indoleamine_NN dioxygenase_NN ._. 
          lifA_NN is_VBZ of_IN limited_JJ phylogenetic_JJ
          distribution_NN ,_, being_VBG present_JJ elsewhere_RB only_RB in_IN
          enteropathogenic_JJ strains_NNS of_IN 
          Escherichia_NNP coli_NNS [_NN 25_CD ]_NN ._. The_DT effect_NN
          of_IN IFN-γ_NNP is_VBZ dose-dependent_JJ [_NN 26_CD ,_, 27_CD ]_NN ,_, and_CC different_JJ
          concentration_NN ranges_NNS have_VBP been_VBN shown_VBN [_NN 28_CD ]_NN to_TO allow_VB rapid_JJ
          progress_NN through_IN the_DT acute_JJ infection_NN cycle_NN (_( low_JJ IFN-γ_NNP
          concentration_NN )_) ,_, to_TO promote_VB a_DT stable_JJ state_NN of_IN persistence_NN
          (_( medium_NN IFN-γ_NNP concentration_NN )_) ,_, or_CC to_TO completely_RB resolve_VB
          the_DT infection_NN (_( high_JJ IFN-γ_NNP concentration_NN )_) ._. Thus_RB ,_, to_TO the_DT
          extent_NN that_DT 
          lifA_NN is_VBZ considered_VBN to_TO be_VB a_DT factor_NN ,_, 
          C_NNP ._. muridarum_NN presumably_RB has_VBZ a_DT
          maximal_NN capability_NN to_TO block_VB induction_NN of_IN IFN-γ_NNP ,_, whereas_IN 
          C_NNP ._. psittaci_NN has_VBZ only_RB a_DT partial_JJ
          ability_NN to_TO block_VB IFN-γ_NNP induction_NN via_IN 
          lifA_NN ._. The_DT amino-terminal_JJ portion_NN of_IN
          
          lifA_NN (_( which_WDT includes_VBZ the_DT remnant_NN of_IN
          
          lifA_NN remaining_VBG in_IN 
          C_NNP ._. trachomatis_NNS )_) is_VBZ homologous_RB to_TO
          the_DT gene_NN encoding_VBG a_DT clostridial_NN toxin_NN ,_, and_CC Belland_NNP 
          et_CC al_NN ._. [_NN 29_CD ]_NN have_VBP recently_RB
          demonstrated_VBN cytotoxic_JJ activities_NNS in_IN 
          C_NNP ._. muridarum_NN and_CC 
          C_NNP ._. trachomatis_NNS D_NNP that_WDT are_VBP
          indistinguishable_JJ from_IN those_DT mediated_JJ by_IN clostridial_NN
          toxin_NN B_NNP ._. Cytotoxicity_NNP was_VBD dose_NN dependent_JJ with_IN respect_NN to_TO 
          lifA_NN copy_NN number_NN ._. Belland_NNP 
          et_CC al_NN ._. [_NN 29_CD ]_NN note_NN that_IN if_IN the_DT
          chlamydial_NN cytotoxin_NN inhibits_NNS lymphocyte_NN activation_NN (_( as_IN
          does_VBZ LifA_NNP in_IN 
          E_NNP ._. coli_NNS )_) ,_, it_PRP would_MD provide_VB a_DT
          mechanism_NN for_IN immune_JJ evasion_NN ._.
          Within_IN the_DT plasticity_NN zone_NN shown_VBN in_IN Figure_NN 1_CD ,_, 
          C_NNP ._. psittaci_NN has_VBZ an_DT operon_NN
          arrangement_NN of_IN genes_NNS encoding_VBG a_DT nearly_RB complete_JJ pathway_NN
          of_IN tryptophan_NN biosynthesis_NNS ._. In_IN contrast_NN ,_, the_DT plasticity_NN
          zone_NN of_IN 
          C_NNP ._. trachomatis_NNS has_VBZ only_RB two_CD
          structural_JJ genes_NNS of_IN tryptophan_NN biosynthesis_NNS (_( 
          trpEb_NN and_CC 
          trpEa_NN )_) ,_, and_CC 
          C_NNP ._. muridarum_NN has_VBZ no_DT
          tryptophan-pathway_JJ genes_NNS at_IN all_DT [_NN 2_CD ]_NN ._. In_IN addition_NN ,_, both_DT 
          C_NNP ._. trachomatis_NNS and_CC 
          C_NNP ._. muridarum_NN have_VBP a_DT 
          trpC_NN gene_NN outside_IN of_IN the_DT plasticity_NN
          zone_NN ._. 
          C_NNP ._. pneumoniae_NN has_VBZ no_DT
          tryptophan-pathway_JJ genes_NNS present_JJ anywhere_RB in_IN the_DT
          genome_NN ._.
        
        
          Novelty_NNP of_IN the_DT tryptophan_NN operon_NN of_IN C_NNP ._.
          psittaci_NN
          The_DT pathway_NN of_IN tryptophan_NN biosynthesis_NNS consists_VBZ of_IN
          five_CD steps_NNS ,_, and_CC we_PRP have_VBP used_VBN the_DT convention_NN [_NN 30_CD ]_NN of_IN
          naming_VBG the_DT genes_NNS in_IN the_DT order_NN of_IN the_DT steps_NNS ,_, 
          trpA_NN ,_, trpB_NN ,_, trpC_NN ,_, trpD_NN and_CC 
          trpE_NN ._. The_DT α_NN and_CC β_NN subunits_NNS of_IN 
          trpA_NN are_VBP named_VBN 
          trpAa_NN and_CC 
          trpAb_NN ,_, and_CC the_DT α_NN and_CC β_NN subunits_NNS of_IN 
          trpE_NN are_VBP named_VBN 
          trpEa_NN and_CC 
          trpEb_NN ._. This_DT nomenclature_NN is_VBZ
          logical_JJ ,_, easy_JJ to_TO remember_VB and_CC suited_VBN to_TO the_DT modern_JJ era_NN of_IN
          comparative_JJ genomics_NNS ,_, where_WRB gene_NN naming_VBG needs_VBZ to_TO be_VB
          consistent_JJ and_CC to_TO correspond_VB to_TO proteins_NNS at_IN the_DT level_NN of_IN
          catalytic_JJ domain_NN (_( subunit_NN )_) ._. Thus_RB ,_, 
          trpAaAbBCDEaEb_NN corresponds_NNS to_TO the_DT
          conventional_JJ 
          E_NNP ._. coli_NNS designations_NNS of_IN 
          trpEGDFCAB_NN ._. 
          The_DT tryptophan_NN operon_NN in_IN 
          C_NNP ._. psittaci_NN is_VBZ incomplete_JJ in_IN that_DT
          genes_NNS encoding_VBG the_DT two_CD subunits_NNS of_IN anthranilate_NN synthase_NN
          (_( 
          trpAa_NN and_CC 
          trpAb_NN )_) are_VBP absent_JJ ._. These_DT genes_NNS are_VBP
          not_RB present_JJ elsewhere_RB in_IN the_DT genome_NN ._. Hence_RB ,_, no_DT
          biochemical_JJ connection_NN with_IN chorismate_NN as_IN a_DT beginning_NN
          substrate_NN for_IN tryptophan_NN biosynthesis_NNS is_VBZ apparent_JJ (_( Figure_NN
          2_LS )_) ._. The_DT tryptophan_NN operon_NN of_IN 
          C_NNP ._. psittaci_NN exhibits_VBZ further_JJ
          striking_JJ aspects_NNS of_IN novelty_NN ._. Not_RB only_RB does_VBZ it_PRP contain_VBP
          genes_NNS (_( 
          kynU_NN and_CC 
          kprS_NN )_) that_WDT are_VBP not_RB components_NNS of_IN
          the_DT classical_JJ tryptophan_NN operon_NN ,_, but_CC these_DT genes_NNS are_VBP not_RB
          even_RB present_JJ in_IN other_JJ chlamydiae_NN ._. 
          kynU_NN encoding_VBG kynureninase_NN and_CC 
          kprS_NN (_( alternative_JJ name_NN :_: 
          prsA_NN )_) encoding_VBG PRPP_NNP synthase_NN are_VBP
          located_VBN at_IN the_DT 3_CD '_POS end_NN of_IN the_DT 
          C_NNP ._. psittaci_NN trp_NN operon_NN (_( see_VB Figure_NN
          1_LS )_) ._. These_DT genes_NNS ,_, together_RB with_IN 
          trpB_NN ,_, trpD_NN ,_, trpC_NN ,_, trpEb_NN and_CC 
          trpEa_NN ,_, comprise_VBP a_DT compact_JJ operon_NN in_IN
          which_WDT all_DT but_CC one_CD gene_NN overlaps_NNS its_PRP$ neighbor_NN in_IN the_DT
          operon_NN (_( translational_NN coupling_NN )_) ._. A_DT regulatory_JJ gene_NN ,_, the_DT 
          trpR_NN repressor_NN ,_, precedes_VBZ the_DT
          tryptophan_NN operon_NN on_IN the_DT amino-terminal_JJ side_NN ._. A_DT second_JJ
          paralog_NN of_IN the_DT tryptophan_NN synthase_NN β_NN subunit_NN (_( 
          trpEb-_NN 2_LS )_) is_VBZ also_RB present_JJ in_IN an_DT
          extra-operonic_JJ location_NN several_JJ genes_NNS upstream_RB of_IN 
          trpR_NN ._. The_DT possible_JJ functional_JJ
          significance_NN of_IN this_DT paralog_NN as_IN serine_NN deaminase_NN has_VBZ been_VBN
          discussed_VBN elsewhere_RB [_NN 30_CD ]_NN ._.
        
        
          Host-parasite_NNP metabolic_JJ mosaic_JJ for_IN tryptophan_NN
          cycling_NN
          A_DT rationale_NN for_IN inclusion_NN of_IN 
          kprS_NN and_CC 
          kynU_NN in_IN the_DT 
          C_NNP ._. psittaci_NN tryptophan_NN operon_NN can_MD
          be_VB visualized_JJ from_IN an_DT examination_NN of_IN Figure_NN 2_CD ._. The_DT
          ability_NN of_IN 
          C_NNP ._. psittaci_NN to_TO synthesize_VB
          L-_NNP tryptophan_NN requires_VBZ an_DT alternative_JJ source_NN of_IN
          anthranilate_NN (_( other_JJ than_IN chorismate_NN )_) as_IN 
          C_NNP ._. psittaci_NN lacks_VBZ anthranilate_NN
          synthase_NN ._. Kynurenine_NNP ,_, intercepted_VBN from_IN the_DT host_NN stream_NN of_IN
          catabolism_NN ,_, would_MD satisfy_VB this_DT requirement_NN given_VBN the_DT
          presence_NN of_IN KynU_NNP ._. PRPP_NNP input_NN is_VBZ required_VBN for_IN the_DT
          TrpB-catalyzed_NNP step_NN ,_, and_CC thus_RB it_PRP was_VBD necessary_JJ for_IN 
          C_NNP ._. psittaci_NN to_TO recruit_VB PRPP_NNP
          synthase_NN (_( 
          kprS_NN )_) to_TO the_DT operon_NN ._. The_DT import_NN of_IN
          ATP_NNP (_( substrate_NN for_IN PRPP_NNP synthase_NN )_) from_IN the_DT host_NN is_VBZ also_RB
          probably_RB needed_VBN ,_, and_CC the_DT presence_NN of_IN ATP_NNP translocases_NNS in_IN
          chlamydial_NN genomes_NNS has_VBZ been_VBN documented_VBN [_NN 1_CD ,_, 2_CD ,_, 3_CD ]_NN ._.
          Alternative_NNP sources_NNS of_IN ATP_NNP ,_, for_IN example_NN ,_, utilization_NN of_IN
          PEP_NNP by_IN pyruvate_NN kinase_NN ,_, are_VBP not_RB altogether_RB ruled_VBD out_IN [_NN
          31_CD ]_NN ._. Finally_RB ,_, serine_NN import_NN is_VBZ required_VBN for_IN the_DT
          tryptophan_NN synthase_NN step_NN as_IN chlamydiae_NN are_VBP not_RB competent_JJ
          for_IN serine_NN biosynthesis_NNS ._.
          Figure_NN 2_CD illustrates_VBZ the_DT mammalian_JJ '_POS kynurenine_NN '_'' pathway_NN
          of_IN tryptophan_NN catabolism_NN ,_, which_WDT is_VBZ prominent_JJ in_IN liver_NN and_CC
          kidney_NN ._. The_DT initial_JJ step_NN is_VBZ rate_NN limiting_VBG and_CC is_VBZ
          catalyzed_JJ by_IN either_DT of_IN two_CD enzymes_NNS :_: indoleamine_NN
          2_CD ,_, 3_CD -_: dioxygenase_NN or_CC tryptophan_NN 2_CD ,_, 3_CD -_: dioxygenase_NN ._. The_DT latter_NN
          is_VBZ the_DT true_JJ catabolic_JJ entity_NN ,_, has_VBZ narrow_JJ specificity_NN for_IN
          tryptophan_NN ,_, and_CC is_VBZ inducible_JJ in_IN the_DT presence_NN of_IN
          tryptophan_NN ,_, glucocorticoids_NNS and_CC heme_NN cofactor_NN [_NN 17_CD ]_NN ._. In_IN
          contrast_NN ,_, indoleamine_NN 2_CD ,_, 3_CD -_: dioxygenase_NN has_VBZ broad_JJ substrate_NN
          specificity_NN and_CC is_VBZ capable_JJ of_IN depleting_VBG low-to-normal_JJ
          concentrations_NNS of_IN tryptophan_NN if_IN induced_VBN by_IN IFN-γ_NNP ._. The_DT
          overall_JJ host_NN metabolism_NN of_IN tryptophan_NN shown_VBN in_IN Figure_NN
          2_CD reflects_VBZ a_DT general_JJ potential_NN that_WDT is_VBZ not_RB necessarily_RB
          realized_VBD in_IN all_DT cell_NN types_NNS ._. The_DT ultimate_JJ catabolic_JJ
          process_NN to_TO generate_VB acetyl-_NN CoA_NNP is_VBZ a_DT feature_NN of_IN liver_NN and_CC
          kidney_NN organ_NN systems_NNS ._. 2_LS -_: Amino-_NNP 3_CD -_: carboxymuconate_NN
          semialdehyde_NN can_MD be_VB considered_VBN to_TO be_VB a_DT branchpoint_NN
          metabolite_NN that_IN either_DT enters_VBZ committed_VBN catabolism_NN to_TO
          acetyl-_NN CoA_NNP or_CC that_DT enters_VBZ biosynthesis_NNS to_TO NAD_NNP +_NN /_NN NADP_NNP +_NN ._.
          In_IN the_DT central_JJ nervous_JJ system_NN ,_, a_DT number_NN of_IN
          kynurenine-pathway_JJ metabolites_NNS are_VBP neuroactive_JJ and_CC appear_VB
          to_TO be_VB involved_VBN in_IN inflammatory_JJ neurological_JJ diseases_NNS [_NN
          32_CD ]_NN ._. Quinolinate_NNP can_MD cause_VB excitotoxic_JJ neuronal_NN death_NN ._.
          Kynurenic_NNP acid_NN ,_, derived_VBN from_IN kynurenine_NN by_IN
          transamination_NN ,_, can_MD antagonize_VB the_DT effect_NN of_IN quinolinate_NN ._.
          3_LS -_: Hydroxykynurenine_NNP and_CC 3_CD -_: hydroxyanthranilate_NN have_VBP been_VBN
          shown_VBN to_TO cause_VB apoptotic_JJ or_CC necrotic_JJ neuronal_NN death_NN in_IN
          cell_NN cultures_NNS [_NN 32_CD ]_NN ._. In_IN glioblastoma_NN cells_NNS (_( and_CC
          apparently_RB in_IN human_JJ fibroblasts_NNS )_) kynurenine_NN is_VBZ an_DT
          endpoint_NN of_IN tryptophan_NN catabolism_NN [_NN 33_CD ]_NN ._. In_IN human_JJ
          macrophages_NNS kynurenine_NN is_VBZ further_RBR metabolized_VBN [_NN 34_CD ]_NN ._.
          Indoleamine_NNP dioxygenase_NN is_VBZ a_DT rate-limiting_JJ step_NN of_IN
          tryptophan_NN catabolism_NN ,_, and_CC other_JJ steps_NNS are_VBP not_RB known_VBN to_TO
          be_VB induced_VBN by_IN IFN-γ_NNP ._. 3_LS -_: Hydroxykynurenine_NNP is_VBZ a_DT prominent_JJ
          metabolite_NN in_IN the_DT eye_NN lens_NN (_( it_PRP absorbs_VBZ UV_NNP radiation_NN )_) and_CC
          probably_RB supports_VBZ eye_NN pigmentation_NN in_IN the_DT iris_NNS /_NN ciliary_JJ
          body_NN [_NN 35_CD ]_NN ._.
          Hence_RB ,_, in_IN some_DT host_NN tissue_NN types_NNS ,_, kynurenine_NN is_VBZ a_DT
          largely_RB dead-end_JJ product_NN of_IN tryptophan_NN catabolism_NN ,_,
          whereas_IN it_PRP has_VBZ a_DT variety_NN of_IN metabolic_JJ fates_NNS in_IN other_JJ
          tissues_NNS ._. In_IN either_DT case_NN ,_, kynurenine_NN generally_RB exhibits_VBZ a_DT
          conspicuous_JJ pool_NN size_NN [_NN 36_CD ]_NN ._. Thus_RB ,_, although_IN 
          C_NNP ._. psittaci_NN apparently_RB cannot_NN
          utilize_VB chorismate_NN (_( for_IN which_WDT it_PRP has_VBZ an_DT intact_JJ
          biosynthetic_JJ pathway_NN )_) as_IN a_DT precursor_NN of_IN L-_NNP tryptophan_NN ,_, it_PRP
          has_VBZ the_DT potential_NN to_TO synthesize_VB its_PRP$ own_JJ supply_NN of_IN
          L-_NNP tryptophan_NN from_IN host-generated_JJ kynurenine_NN ,_, ATP_NNP and_CC
          L-_NNP serine_NN ._.
          It_PRP is_VBZ of_IN interest_NN that_IN the_DT conversion_NN of_IN kynurenine_NN to_TO
          anthranilate_NN and_CC the_DT conversion_NN of_IN 3_CD -_: hydroxykynurenine_NN to_TO
          3_CD -_: hydroxyathranilate_NN are_VBP similar_JJ hydrolytic_JJ reactions_NNS ._.
          The_DT host_NN enzyme_NN catalyzing_VBG the_DT latter_JJ reaction_NN is_VBZ ,_, in_IN
          fact_NN ,_, a_DT kynureninase_NN which_WDT is_VBZ a_DT homolog_NN of_IN the_DT 
          C_NNP ._. psittaci_NN KynU_NNP ._. Kynureninases_NNP
          have_VBP been_VBN reported_VBN to_TO possess_VB a_DT range_NN of_IN substrate_NN
          specificities_NNS that_WDT vary_VBP between_IN very_RB high_JJ specificity_NN for_IN
          kynurenine_NN and_CC very_RB high_JJ specificity_NN for_IN
          3_CD -_: hydroxykynurenine_NN ._. The_DT kynureninase_NN of_IN rat_NN and_CC human_JJ
          liver_NN has_VBZ an_DT order-of-magnitude_JJ preference_NN for_IN
          3_CD -_: hydroxykynurenine_NN [_NN 37_CD ]_NN ,_, in_IN contrast_NN to_TO a_DT microbial_NN
          kynureninase_NN that_WDT exhibits_VBZ a_DT very_RB high_JJ preference_NN for_IN
          kynurenine_NN [_NN 38_CD ]_NN ._. It_PRP seems_VBZ likely_JJ that_IN the_DT 
          C_NNP ._. psittaci_NN KynU_NNP is_VBZ specific_JJ for_IN
          kynurenine_NN ,_, whereas_IN the_DT mammalian_JJ host_NN may_MD possess_VB
          isozymes_NNS of_IN different_JJ substrate_NN specificity_NN in_IN different_JJ
          tissues_NNS ._.
          An_DT intriguing_JJ possible_JJ layer_NN of_IN additional_JJ complexity_NN
          involves_VBZ a_DT competitive_JJ relationship_NN between_IN indoleamine_NN
          dioxygenase_NN and_CC nitric_JJ oxide_NN (_( NO_DT )_) synthase_NN (_( type_NN II_NNP
          isoform_NN )_) ,_, which_WDT are_VBP both_DT induced_VBN by_IN IFN-γ_NNP ._. In_IN murine_NN
          macrophages_NNS ,_, induction_NN of_IN NO_DT synthase_NN requires_VBZ at_IN least_JJS
          one_CD additional_JJ stimulus_NN (_( such_JJ as_IN bacterial_JJ
          lipopolysaccharide_NN (_( LPS_NNP )_) )_) that_IN acts_NNS synergistically_RB with_IN
          IFN-γ_NNP (_( [_NN 39_CD ]_NN and_CC references_NNS therein_RB )_) ._. Metabolite_NNP flow_NN to_TO
          NAD_NNP +_NN is_VBZ proportional_JJ to_TO the_DT input_NN availability_NN of_IN
          tryptophan_NN in_IN murine_NN macrophages_NNS [_NN 40_CD ]_NN ._. Under_IN conditions_NNS
          in_IN which_WDT there_EX is_VBZ induction_NN of_IN both_DT indoleamine_NN
          dioxygenase_NN and_CC NO_DT synthase_NN ,_, an_DT interplay_NN of_IN potential_JJ
          cross-pathway_JJ inhibitions_NNS are_VBP set_VBN in_IN motion_NN as_IN
          illustrated_VBN in_IN Figure_NN 2_CD ._. Nitric_NNP oxide_NN inhibits_NNS
          indoleamine_NN dioxygenase_NN [_NN 41_CD ]_NN ._. On_IN the_DT other_JJ hand_NN ,_,
          3_CD -_: hydroxyanthranilate_NN inhibits_NNS both_DT the_DT expression_NN and_CC
          activity_NN of_IN NO_DT synthase_NN [_NN 39_CD ]_NN ._. Thus_RB ,_, small-molecule_JJ
          products_NNS of_IN each_DT pathway_NN can_MD be_VB mutually_RB inhibitory_NN ._.
          Consider_VB a_DT scenario_NN where_WRB 
          C_NNP ._. psittaci_NN has_VBZ parasitized_JJ a_DT host_NN
          niche_NN where_WRB 3_CD -_: hydroxyanthranilate_NN is_VBZ a_DT prominent_JJ
          metabolite_NN ,_, as_IN in_IN human_JJ macrophages_NNS [_NN 42_CD ]_NN ._. The_DT withdrawal_NN
          of_IN kynurenine_NN from_IN this_DT flow_NN route_NN might_MD undermine_VB the_DT
          levels_NNS of_IN 3_CD -_: hydroxyanthranilate_NN sufficiently_RB to_TO release_VB
          the_DT restraints_NNS on_IN NO_DT synthase_NN ._. The_DT consequent_JJ increase_NN in_IN
          nitric_JJ oxide_NN production_NN might_MD then_RB tend_VB to_TO limit_VB the_DT
          availability_NN of_IN kynurenine_NN as_IN a_DT result_NN of_IN inhibition_NN of_IN
          indoleamine_NN dioxygenase_NN ._. Although_IN this_DT might_MD at_IN first_JJ
          seem_VB an_DT unfavorable_JJ outcome_NN for_IN the_DT 
          C_NNP ._. psittaci_NN parasitism_NN ,_, a_DT finite_JJ
          but_CC minimal_JJ supply_NN of_IN kynurenine_NN might_MD satisfy_VB the_DT highly_RB
          limited_JJ metabolic_JJ demands_NNS of_IN the_DT persistent_JJ state_NN ._.
        
        
          Did_VBD the_DT C_NNP ._. psittaci_NN trpoperon_NN originate_VB by_IN lateral_NN
          gene_NN transfer_NN ?_.
          The_DT tryptophan_NN operon_NN of_IN 
          C_NNP ._. psittaci_NN is_VBZ probably_RB derived_VBN
          from_IN ancestral_JJ chlamydial_NN genes_NNS before_IN modern_JJ events_NNS of_IN
          gene_NN reduction_NN occurred_VBD ._. However_RB ,_, as_IN the_DT present-day_JJ 
          C_NNP ._. psittaci_NN operon_NN is_VBZ unique_JJ among_IN
          chlamydiae_NN ,_, it_PRP is_VBZ also_RB possible_JJ that_IN 
          trp_NN genes_NNS were_VBD lost_VBN and_CC then_RB
          reacquired_JJ by_IN lateral_NN gene_NN transfer_NN (_( LGT_NNP )_) ._. As_IN this_DT would_MD
          have_VB happened_VBN recently_RB (_( after_IN divergence_NN of_IN 
          C_NNP ._. psittaci_NN from_IN other_JJ chlamydial_NN
          lineages_NNS )_) ,_, one_PRP might_MD then_RB expect_VB the_DT genes_NNS to_TO have_VB GC_NNP
          contents_NNS different_JJ from_IN that_DT of_IN the_DT overall_JJ 
          C_NNP ._. psittaci_NN genome_NN (_( 42_CD %_NN )_) ._. Table_NNP
          1_CD shows_VBZ that_IN each_DT operon_NN gene_NN ,_, as_RB well_RB as_IN 
          trpR_NN and_CC 
          trpEb-_NN 2_CD ,_, are_VBP within_IN the_DT range_NN
          expected_VBN for_IN 
          C_NNP ._. psittaci_NN ._. However_RB ,_, the_DT GC_NNP
          content_NN of_IN the_DT donor_NN genome_NN could_MD have_VB fortuitously_RB been_VBN
          near_IN that_DT of_IN 
          C_NNP ._. psittaci_NN ._. If_IN so_RB ,_, one_PRP might_MD
          expect_VB that_IN the_DT top_JJ hits_NNS returned_VBD from_IN a_DT BLAST_NN search_NN of_IN
          each_DT 
          C_NNP ._. psittaci_NN operon_NN gene_NN would_MD not_RB
          include_VB other_JJ chlamydial_NN genes_NNS and_CC would_MD be_VB dominated_VBN by_IN
          one_CD organism_NN having_VBG an_DT appropriate_JJ GC_NNP content_NN ._. The_DT
          results_NNS (_( Table_NNP 1_LS )_) show_NN that_IN this_DT expectation_NN was_VBD not_RB
          realized_VBN ._.
          It_PRP is_VBZ perhaps_RB intriguing_JJ that_IN when_WRB 
          C_NNP ._. psittaci_NN kynureninase_NN (_( KynU_NNP )_) was_VBD
          used_VBN as_IN a_DT query_NN sequence_NN ,_, the_DT top_JJ hits_NNS returned_VBD from_IN
          BLAST_NN were_VBD the_DT KynU_NNP orthologs_NNS from_IN man_NN and_CC mouse_NN ._.
          Accordingly_RB ,_, the_DT codon_NN usage_NN for_IN the_DT KynU_NNP proteins_NNS of_IN 
          C_NNP ._. psittaci_NN and_CC 
          Homo_NN sapiens_JJ (_( left_VBD half_NN of_IN Figure_NN
          3_LS )_) was_VBD compared_VBN with_IN the_DT genomic_JJ codon_NN usage_NN of_IN the_DT
          respective_JJ organisms_NNS (_( right_JJ half_NN of_IN Figure_NN 3_LS )_) ._. The_DT codon_NN
          usage_NN for_IN arginine_NN ,_, leucine_NN ,_, proline_NN and_CC valine_NN is_VBZ
          distinctive_JJ in_IN a_DT comparison_NN of_IN 
          C_NNP ._. psittaci_NN and_CC 
          H_NNP ._. sapiens_JJ ._. The_DT profile_NN of_IN codon_NN
          usage_NN for_IN these_DT amino_JJ acids_NNS by_IN 
          C_NNP ._. psittaci_NN KynU_NNP clearly_RB matches_VBZ
          the_DT genomic_JJ codon-usage_JJ profile_NN of_IN 
          C_NNP ._. psittaci_NN ,_, but_CC not_RB that_IN of_IN 
          H_NNP ._. sapiens_JJ ._. Thus_RB ,_, there_EX is_VBZ no_DT
          evidence_NN for_IN a_DT recent_JJ LGT_NNP of_IN 
          kynU_NN between_IN 
          C_NNP ._. psittaci_NN and_CC 
          H_NNP ._. sapiens_JJ ._. 
        
        
          Deterioration_NNP of_IN tryptophan-pathway_JJ genes_NNS in_IN the_DT
          chlamydiae_NN
          Chlamydial_NNP species_NNS have_VBP generally_RB undergone_VBN reductive_JJ
          evolution_NN that_WDT includes_VBZ an_DT inability_NN to_TO synthesize_VB
          tryptophan_NN from_IN chorismate_NN ._. That_DT the_DT process_NN of_IN reductive_JJ
          evolution_NN is_VBZ ongoing_JJ is_VBZ suggested_VBN by_IN the_DT variability_NN of_IN
          remaining_VBG remnants_NNS and_CC by_IN indications_NNS that_IN some_DT of_IN these_DT
          remnants_NNS are_VBP pseudogenes_NNS ._. At_IN one_CD extreme_JJ ,_, 
          C_NNP ._. pneumoniae_NN has_VBZ lost_VBN all_DT
          tryptophan-pathway_JJ genes_NNS ;_: 
          C_NNP ._. muridarum_NN has_VBZ only_RB one_CD remnant_NN (_(
          
          trpC_NN )_) ;_: and_CC 
          C_NNP ._. trachomatis_NNS has_VBZ three_CD remnants_NNS (_(
          
          trpC_NN ,_, trpEa_NN and_CC 
          trpEb_NN )_) ._. It_PRP appears_VBZ that_IN 
          C_NNP ._. psittaci_NN alone_RB assigns_VBZ a_DT
          functional_JJ role_NN to_TO tryptophan-pathway_JJ genes_NNS ,_, but_CC it_PRP is_VBZ a_DT
          kynurenine-to-tryptophan_JJ pathway_NN rather_RB than_IN a_DT
          chorismate-to-tryptophan_JJ pathway_NN ._. Thus_RB ,_, even_RB 
          C_NNP ._. psittaci_NN is_VBZ dependent_JJ upon_IN host_NN
          resources_NNS (_( that_WDT is_VBZ ,_, kynurenine_NN )_) for_IN tryptophan_NN ._.
          Figure_NN 4_CD shows_VBZ a_DT sequence_NN comparison_NN of_IN TrpC_NNP from_IN 
          E_NNP ._. coli_NNS with_IN those_DT from_IN chlamydial_NN
          species_NNS ._. Critical_JJ residues_NNS can_MD be_VB assessed_VBN with_IN guidance_NN
          from_IN X-_NNP ray_NN crystallography_NN data_NNS (_( see_VB legend_NN )_) and_CC
          invariant_NN residues_NNS seen_VBN in_IN multiple_JJ alignments_NNS ._. Given_VBN the_DT
          presumed_VBN lack_NN of_IN selection_NN for_IN function_NN in_IN 
          C_NNP ._. trachomatis_NNS and_CC 
          C_NNP ._. muridarum_NN ,_, it_PRP would_MD not_RB be_VB
          surprising_JJ to_TO find_VB evidence_NN of_IN unfavorable_JJ mutations_NNS ._.
          Indeed_RB ,_, the_DT mutations_NNS H_NNP 335_CD →_NN S_NNP 335_CD (_( 
          E_NNP ._. coli_NNS numbering_VBG )_) and_CC G_NNP 385_CD →_NN E_NNP 385_CD
          in_IN 
          C_NNP ._. trachomatis_NNS and_CC 
          C_NNP ._. muridarum_NN ,_, but_CC not_RB in_IN 
          C_NNP ._. psittaci_NN ,_, probably_RB reflect_VB
          unfavorable_JJ catalytic_JJ alterations_NNS (_( see_VB heavy_JJ up_RP arrows_NNS in_IN
          Figure_NN 4_LS )_) ._. Two_CD changes_NNS in_IN 
          C_NNP ._. psittaci_NN ,_, not_RB present_JJ in_IN the_DT
          other_JJ two_CD chlamydial_NN species_NNS (_( V_NNP 292_CD →_NN T_NN 292_CD and_CC S_NNP 429_CD →_NN
          T_NN 429_CD )_) are_VBP conservative_JJ changes_NNS that_WDT are_VBP presumably_RB
          tolerated_JJ ._.
          TrpEa_NNP from_IN 
          C_NNP ._. trachomatis_NNS has_VBZ clearly_RB
          accumulated_VBN deleterious_JJ mutations_NNS in_IN contrast_NN to_TO the_DT 
          C_NNP ._. psittaci_NN TrpEa_NNP (_( Figure_NN 5_LS )_) ._.
          Comparison_NNP of_IN these_DT sequences_NNS with_IN that_DT of_IN the_DT well_NN
          studied_VBN TrpEa_NNP from_IN 
          Salmonella_NNP typhimurium_NN shows_VBZ 
          C_NNP ._. trachomatis_NNS TrpEa_NNP (_( but_CC not_RB 
          C_NNP ._. psittaci_NN TrpEa_NNP )_) to_TO have_VB the_DT
          following_VBG changes_NNS at_IN critical_JJ residues_NNS (_( 
          S_NNP ._. typhimurium_NN numbering_VBG )_) :_: G_NNP 61_CD →_NN
          N_NNP 61_CD ,_, G_NNP 211_CD →_NN R_NN 211_CD ,_, F_NN /_NN L_NNP 212_CD →_NN R_NN 212_CD ,_, and_CC G_NNP 234_CD →_NN K_NNP 234_CD ._. In_IN
          addition_NN ,_, the_DT intersubunit_NN signaling_VBG residue_NN G_NNP 181_CD has_VBZ
          been_VBN changed_VBN to_TO A_DT 181_CD in_IN 
          C_NNP ._. trachomatis_NNS ._. C_NNP ._.
          trachomatis_NNS TrpEa_NNP has_VBZ a_DT four-residue_JJ deletion_NN between_IN
          R_NN 192_CD and_CC K_NNP 193_CD that_WDT is_VBZ unique_JJ in_IN our_PRP$ comprehensive_JJ
          alignment_NN of_IN TrpEa_NNP ._. Xie_NNP 
          et_CC al_NN ._. [_NN 30_CD ]_NN pointed_VBD out_RP that_IN the_DT
          elongated_JJ branch_NN of_IN 
          C_NNP ._. trachomatis_NNS TrpEa_NNP ,_, but_CC not_RB of_IN 
          C_NNP ._. psittaci_NN TrpEa_NNP ,_, on_IN an_DT unrooted_JJ
          phylogenetic_JJ tree_NN of_IN the_DT TrpEa_NNP family_NN was_VBD consistent_JJ with_IN
          a_DT likely_JJ pseudogene_NN status_NN for_IN the_DT former_NN ._. The_DT rapid_JJ
          deterioration_NN of_IN TrpEa_NNP is_VBZ ,_, in_IN fact_NN ,_, apparent_JJ from_IN
          differences_NNS in_IN TrpEa_NNP from_IN various_JJ serovars_NNS of_IN 
          C_NNP ._. trachomatis_NNS [_NN 43_CD ]_NN ._. Thus_RB ,_, serovar_NN
          B_NNP lacks_VBZ TrpEa_NNP altogether_RB ,_, serovars_NNS A_DT and_CC C_NNP express_VBP
          severely_RB truncated_JJ TrpEa_NNP proteins_NNS ,_, whereas_IN serovars_NNS D_NNP and_CC
          L_NNP 2_CD express_VB full-length_JJ TrpEa_NNP proteins_NNS (_( although_IN
          undoubtedly_RB inactive_JJ )_) ._.
          The_DT β_NN subunits_NNS of_IN tryptophan_NN synthase_NN in_IN 
          C_NNP ._. psittaci_NN (_( two_CD copies_NNS ,_, Figure_NN 1_LS )_)
          and_CC 
          C_NNP ._. trachomatis_NNS appear_VBP to_TO have_VB all_DT
          important_JJ residues_NNS conserved_JJ (_( Figure_NN 6_CD )_) ._. This_DT includes_VBZ
          conserved_JJ catalytic_JJ residues_NNS and_CC residues_NNS that_WDT are_VBP
          important_JJ for_IN establishing_VBG intersubunit_NN and_CC intrasubunit_NN
          salt_NN bridges_NNS needed_VBN for_IN formation_NN of_IN the_DT α-β_JJ complex_NN of_IN
          tryptophan_NN synthase_NN ._. It_PRP appears_VBZ that_IN there_EX has_VBZ been_VBN rapid_JJ
          deterioration_NN of_IN TrpEa_NNP ,_, but_CC not_RB of_IN TrpEb_NNP ._. This_DT might_MD
          suggest_VB that_IN TrpEb_NNP is_VBZ under_IN positive_JJ selection_NN for_IN some_DT
          functional_JJ role_NN other_JJ than_IN that_DT of_IN tryptophan_NN synthase_NN ._.
          When_WRB TrpEb_NNP is_VBZ not_RB complexed_JJ with_IN TrpEa_NNP ,_, it_PRP has_VBZ
          substantial_JJ activity_NN as_IN serine_NN deaminase_NN ._. Therefore_RB ,_,
          present-day_JJ TrpEb_NNP may_MD function_VB in_IN the_DT chlamydiae_NN as_IN
          serine_NN deaminase_NN ,_, as_IN has_VBZ been_VBN proposed_VBN by_IN Xie_NNP 
          et_CC al_NN ._. [_NN 30_CD ]_NN for_IN some_DT archaea_NN ._. This_DT
          is_VBZ consistent_JJ with_IN the_DT total_JJ absence_NN of_IN genes_NNS in_IN
          chlamydiae_NN known_VBN to_TO encode_NN enzymes_NNS with_IN serine_NN deaminase_NN
          activity_NN ._. These_DT enzymes_NNS include_VBP Fe-_NNP S_NNP serine_NN deaminase_NN
          (_( GenBank_NNP gi_NN 2501150_CD )_) ,_, PLP-dependent_NNP serine_NN deaminase_NN (_( gi_NN
          134387_CD )_) ,_, catabolic_JJ threonine_NN deaminase_NN (_( gi_NN 135723_CD )_) ,_, and_CC
          biosynthetic_JJ threonine_NN deaminase_NN (_( gi_NN 135720_CD )_) ._.
          A_DT very_RB recent_JJ paper_NN by_IN Fehlner-_NNP Gardiner_NNP 
          et_CC al_NN ._. [_NN 44_CD ]_NN affirms_NNS experimentally_RB
          the_DT predictions_NNS made_VBN in_IN this_DT paper_NN that_IN TrpEb_NNP should_MD be_VB
          functional_JJ and_CC TrpEa_NNP should_MD not_RB be_VB functional_JJ ._.
          Fehlner-_NNP Gardiner_NNP 
          et_CC al_NN ._. [_NN 44_CD ]_NN sequenced_JJ TrpEa_NNP and_CC
          TrpEb_NNP from_IN all_DT human_JJ serovars_NNS of_IN 
          C_NNP ._. trachomatis_NNS ._. All_DT of_IN the_DT genital_JJ
          serovars_NNS expressed_VBD TrpEa_NNP and_CC TrpEb_NNP proteins_NNS ,_, but_CC only_RB
          TrpEb_NNP had_VBD catalytic_JJ activity_NN ._. Interestingly_RB ,_, the_DT
          catalytic_JJ indole-utilizing_JJ activity_NN of_IN TrpEb_NNP required_VBD a_DT
          full-length_JJ TrpEa_NNP ._. It_PRP appears_VBZ that_IN these_DT TrpEa_NNP proteins_NNS ,_,
          although_IN lacking_VBG their_PRP$ own_JJ catalytic_JJ activity_NN ,_, are_VBP still_RB
          functional_JJ in_IN maintaining_VBG the_DT TrpEb_NNP activity_NN ._. Even_RB though_IN
          most_JJS of_IN the_DT ocular_NN serovars_NNS also_RB had_VBD a_DT potentially_RB
          functional_JJ TrpEb_NNP ,_, none_NN of_IN them_PRP would_MD presumably_RB utilize_VB
          indole_NN 
          in_IN vivo_NN because_IN of_IN the_DT absence_NN of_IN a_DT
          full-length_JJ TrpEa_NNP ._. The_DT authors_NNS propose_VBP that_IN other_JJ
          bacteria_NNS in_IN the_DT microenvironment_NN of_IN genital_JJ serovars_NNS
          might_MD be_VB a_DT source_NN of_IN indole_NN ,_, a_DT situation_NN not_RB expected_VBD in_IN
          the_DT microenvironment_NN of_IN ocular_NN serovars_NNS ._. In_IN short_JJ ,_, the_DT
          tissue_NN tropism_NN correlates_NNS with_IN ability_NN to_TO convert_VB indole_NN
          to_TO L-_NNP tryptophan_NN 
          in_IN vivo_NN ._. This_DT seems_VBZ a_DT reasonable_JJ
          possibility_NN ,_, although_IN it_PRP does_VBZ not_RB explain_VB why_WRB most_JJS of_IN the_DT
          ocular_NN serovars_NNS have_VBP maintained_VBN a_DT TrpEb_NNP that_WDT seems_VBZ to_TO
          have_VB resisted_VBN reductive_JJ evolutionary_JJ forces_NNS ._. It_PRP would_MD be_VB
          interesting_JJ to_TO know_VB whether_IN the_DT serine_NN deaminase_NN activity_NN
          of_IN 
          C_NNP ._. trachomatis_NNS TrpEb_NNP (_( an_DT activity_NN
          other_JJ than_IN indole_NN utilization_NN suggested_VBD in_IN this_DT paper_NN )_)
          requires_VBZ full-length_JJ TrpEa_NNP or_CC not_RB ._.
        
        
          Overview_NNP of_IN tryptophan-pathway_JJ variability_NN in_IN
          chlamydiae_NN
          Shaw_NNP 
          et_CC al_NN ._. [_NN 43_CD ]_NN have_VBP correlated_JJ the_DT
          variability_NN in_IN the_DT number_NN of_IN tryptophan-pathway_JJ enzymes_NNS
          present_JJ in_IN chlamydiae_NN (_( in_IN particular_JJ ,_, the_DT α_NN subunit_NN of_IN
          tryptophan_NN synthase_NN )_) with_IN varied_JJ sensitivity_NN to_TO IFN-γ_NNP
          treatment_NN [_NN 16_CD ]_NN and_CC ease_NN of_IN demonstrating_VBG the_DT transition_NN
          to_TO persistence_NN 
          in_IN vitro_NN ._. C_NNP ._. trachomatis_NNS A_DT ,_, B_NNP and_CC C_NNP
          readily_RB develop_VBP persistent_JJ characteristics_NNS following_VBG
          IFN-γ_NNP treatment_NN ._. 
          C_NNP ._. pneumoniae_NN also_RB is_VBZ readily_RB
          converted_VBN to_TO persistence_NN with_IN IFN-γ_NNP treatment_NN [_NN 45_CD ]_NN ._.
          Tryptophan_NNP has_VBZ been_VBN reported_VBN to_TO be_VB essential_JJ for_IN growth_NN
          of_IN serovars_NNS A_DT ,_, B_NNP and_CC C_NNP ,_, but_CC not_RB for_IN growth_NN of_IN 
          C_NNP ._. psittaci_NN or_CC serovars_NNS D-K_NNP and_CC L_NNP 2_CD
          of_IN 
          C_NNP ._. trachomatis_NNS [_NN 45_CD ]_NN ._. Thus_RB ,_, 
          C_NNP ._. trachomatis_NNS serovars_NNS A-C_NNP ,_, but_CC
          not_RB serovars_NNS D-K_NNP or_CC L_NNP 1_CD -_: L_NNP 3_CD ,_, have_VBP been_VBN described_VBN as_IN
          '_POS tryptophan_NN auxotrophs_NNS '_POS [_NN 43_CD ]_NN ._. Likewise_RB ,_, 
          C_NNP ._. pneumoniae_NN ,_, but_CC not_RB 
          C_NNP ._. psittaci_NN ,_, has_VBZ been_VBN described_VBN as_IN
          a_DT tryptophan_NN auxotroph_NN ._. Morrison_NNP [_NN 46_CD ]_NN has_VBZ also_RB discussed_VBN
          the_DT possible_JJ relationship_NN of_IN genes_NNS present_JJ or_CC absent_JJ for_IN
          tryptophan_NN biosynthesis_NNS and_CC the_DT differential_NN
          sensitivities_NNS of_IN chlamydiae_NN to_TO inhibitory_NN effects_NNS of_IN
          IFN-γ_NNP ._. Shaw_NNP 
          et_CC al_NN ._. [_NN 43_CD ]_NN imply_VBP that_IN 
          C_NNP ._. trachomatis_NNS D_NNP ,_, L_NNP 2_CD and_CC 
          C_NNP ._. psittaci_NN are_VBP competent_JJ for_IN
          tryptophan_NN biosynthesis_NNS ,_, unlike_IN 
          C_NNP ._. trachomatis_NNS A_DT ,_, B_NNP ,_, C_NNP and_CC 
          C_NNP ._. pneumoniae_NN ._. This_DT correlates_NNS
          nicely_RB with_IN proneness_NNS to_TO persistence_NN and_CC the_DT more_RBR
          demonstrable_JJ nutritional_JJ requirement_NN for_IN tryptophan_NN in_IN
          the_DT latter_JJ strains_NNS ,_, but_CC not_RB the_DT former_NN ._. However_RB ,_, from_IN the_DT
          current_JJ database_NN information_NN available_JJ ,_, it_PRP appears_VBZ likely_JJ
          that_IN all_DT chlamydiae_NN ,_, even_RB 
          C_NNP ._. psittaci_NN ,_, are_VBP tryptophan_NN
          auxotrophs_NNS ._. As_IN the_DT host_NN itself_PRP is_VBZ incapable_JJ of_IN tryptophan_NN
          biosynthesis_NNS ,_, the_DT host_NN is_VBZ not_RB a_DT credible_JJ source_NN of_IN any_DT
          biosynthetic_JJ intermediates_NNS ._. It_PRP is_VBZ also_RB noteworthy_JJ that_IN
          only_RB 
          C_NNP ._. psittaci_NN has_VBZ PRPP_NNP synthase_NN ,_,
          which_WDT is_VBZ needed_VBN for_IN provision_NN of_IN PRPP_NNP (_( TrpB_NNP step_NN )_) ._. Thus_RB ,_,
          there_EX seems_VBZ to_TO be_VB no_DT basis_NN for_IN the_DT conclusion_NN [_NN 43_CD ]_NN that_IN
          variations_NNS in_IN 
          C_NNP ._. trachomatis_NNS serovar_NN pathogenesis_NNS
          can_MD be_VB directly_RB linked_VBN to_TO differences_NNS in_IN TrpEa_NNP ,_, and_CC it_PRP
          therefore_RB seems_VBZ that_IN the_DT latter_JJ differences_NNS are_VBP
          coincidental_JJ ._. Differential_NNP capabilities_NNS for_IN acquisition_NN
          of_IN the_DT host_NN resources_NNS are_VBP unknown_JJ variables_NNS that_WDT might_MD
          distinguish_VB different_JJ strains_NNS [_NN 47_CD ]_NN ._. In_IN this_DT context_NN ,_, it_PRP
          seems_VBZ possible_JJ that_DT variation_NN in_IN LifA_NNP integrity_NN or_CC copy_NN
          number_NN could_MD easily_RB explain_VB variation_NN in_IN IFN-γ_NNP
          sensitivity_NN and_CC the_DT nutritional_JJ requirement_NN for_IN
          L-_NNP tryptophan_NN 
          in_IN vitro_NN ._. 
          Except_IN for_IN 
          C_NNP ._. psittaci_NN ,_, we_PRP may_MD be_VB seeing_VBG
          different_JJ strains_NNS in_IN varied_VBD states_NNS of_IN reductive_JJ evolution_NN
          with_IN respect_NN to_TO what_WP remnants_NNS of_IN genes_NNS for_IN tryptophan_NN
          biosynthesis_NNS remain_VBP ._. 
          C_NNP ._. pneumoniae_NN and_CC 
          C_NNP ._. trachomatis_NNS B_NNP lack_NN genes_NNS
          encoding_VBG the_DT entire_JJ tryptophan_NN pathway_NN ._. 
          C_NNP ._. trachomatis_NNS D_NNP possesses_VBZ 
          trpC_NN ,_, trpEa_NN and_CC 
          trpEb_NN ;_: C_NNP ._. muridarum_NN possesses_VBZ only_RB 
          trpC_NN ;_: C_NNP ._. trachomatis_NNS A_DT and_CC C_NNP
          possess_VBP 
          trpEa_NN and_CC 
          trpEb_NN ._. The_DT truncation_NN of_IN 
          trpEa_NN in_IN 
          C_NNP ._. trachomatis_NNS A_DT and_CC C_NNP ,_, the_DT likely_JJ
          pseudogene_NN status_NN of_IN 
          trpEa_NN in_IN serovar_NN D_NNP ,_, and_CC the_DT absence_NN
          of_IN 
          trpEa_NN altogether_RB in_IN serovar_NN B_NNP
          indicates_VBZ an_DT active_JJ ongoing_JJ process_NN of_IN reductive_JJ
          evolution_NN ._.
        
        
          Chlamydial_NNP transport_NN of_IN tryptophan_NN ,_, kynurenine_NN and_CC
          serine_NN
          The_DT chlamydiae_NN are_VBP dependent_JJ on_IN host_NN cells_NNS for_IN a_DT
          variety_NN of_IN metabolites_NNS that_WDT are_VBP relevant_JJ to_TO the_DT
          host-parasite_JJ relationships_NNS of_IN tryptophan_NN metabolism_NN ._.
          These_DT include_VBP kynurenine_NN ,_, serine_NN ,_, ATP_NNP and_CC tryptophan_NN
          itself_PRP ._. Hence_RB ,_, the_DT nature_NN and_CC variability_NN for_IN transport_NN
          of_IN these_DT compounds_NNS should_MD be_VB of_IN considerable_JJ
          interest_NN ._.
          Species_NNP of_IN chlamydiae_NN possess_VBP one_CD (_( 
          C_NNP ._. psittaci_NN )_) or_CC two_CD (_( 
          C_NNP ._. muridarum_NN ,_, C_NNP ._. trachomatis_NNS and_CC 
          C_NNP ._. pneumoniae_NN )_) homologs_NNS of_IN genes_NNS
          encoding_VBG the_DT well_NN characterized_VBN hydroxy_NN /_NN aromatic_JJ amino_JJ
          acid_NN (_( HAAAP_NNP )_) permease_NN family_NN [_NN 48_CD ]_NN ._. Figure_NN 7_CD presents_VBZ an_DT
          unrooted_JJ radial_NN tree_NN that_WDT shows_VBZ the_DT chlamydial_NN proteins_NNS
          to_TO comprise_VB a_DT distinct_JJ cluster_NN ._. 
          E_NNP ._. coli_NNS Mtr_NNP (_( high-affinity_JJ
          tryptophan_NN permease_NN )_) and_CC TnaB_NNP (_( low-affinity_JJ tryptophan_NN
          permease_NN )_) comprise_VBP one_CD distinct_JJ group_NN ,_, and_CC 
          E_NNP ._. coli_NNS TyrP_NNP homologs_NNS make_VBP up_RP
          another_DT distinct_JJ group_NN ._. The_DT chlamydial_NN sequences_NNS are_VBP
          approximately_RB equidistant_NN from_IN the_DT TyrP_NNP /_NN Mtr-_NNP TnaB_NNP
          groupings_NNS ._. These_DT chlamydial_NN proteins_NNS might_MD be_VB
          broad-specificity_JJ transporters_NNS of_IN tryptophan_NN ,_, tyrosine_NN ,_,
          phenylalanine_NN and_CC perhaps_RB kynurenine_NN as_RB well_RB ._.
          When_WRB the_DT Na_NNP +_NN -_: coupled_VBN serine_NN symporter_NN SdaC_NNP from_IN 
          E_NNP ._. coli_NNS was_VBD used_VBN as_IN a_DT query_NN against_IN
          the_DT chlamydial_NN genomes_NNS ,_, TyrP_NNP was_VBD the_DT top_NN hit_NN (_( 22_CD %_NN
          identity_NN )_) ._. This_DT reflects_VBZ the_DT membership_NN of_IN SdaC_NNP proteins_NNS
          in_IN the_DT HAAAP_NNP family_NN ._. An_DT alternative_JJ query_NN ,_, the_DT 
          E_NNP ._. coli_NNS CycA_NNP serine_NN /_NN alanine_NN /_NN glycine_NN
          transporter_NN ,_, yielded_VBD CT_NNP 216_CD as_IN the_DT top_NN hit_NN (_( only_RB 22_CD %_NN
          identity_NN )_) ._. 
          E_NNP ._. coli_NNS possesses_VBZ a_DT Na_NNP +_NN -_: coupled_VBN
          serine_NN symporter_NN ,_, SttT_NNP ,_, which_WDT is_VBZ regulated_VBN by_IN tryptophan_NN
          [_NN 49_CD ]_NN ._. Although_IN this_DT is_VBZ but_CC one_CD of_IN at_IN least_JJS five_CD
          different_JJ transporters_NNS for_IN serine_NN in_IN 
          E_NNP ._. coli_NNS ,_, sstT_NN encodes_NNS the_DT sole_JJ
          serine_NN /_NN threonine_NN transporter_NN in_IN 
          Porphyromonas_NNP gingivalis_NNS [_NN 50_CD ]_NN ._.
          Species_NNP of_IN chlamydiae_NN possess_VBP two_CD paralogs_NNS of_IN SstT_NNP ,_, which_WDT
          were_VBD judged_VBN to_TO be_VB the_DT most_RBS likely_JJ genes_NNS encoding_VBG serine_NN
          transport_NN ._. Perhaps_RB one_CD favors_VBZ serine_NN transport_NN and_CC the_DT
          other_JJ threonine_NN transport_NN ._. Figure_NN 8_CD shows_VBZ an_DT unrooted_JJ tree_NN
          of_IN SstT_NNP proteins_NNS ._.
        
        
          The_DT tryptophan_NN repressor_NN
          The_DT presence_NN of_IN 
          trpR_NN implies_VBZ that_IN the_DT tryptophan_NN
          operon_NN is_VBZ under_IN repression_NN control_NN by_IN L-_NNP tryptophan_NN ,_, and_CC
          some_DT experimental_JJ evidence_NN does_VBZ indeed_RB show_NN derepression_NN
          under_IN conditions_NNS of_IN tryptophan_NN limitation_NN [_NN 43_CD ]_NN ._.
          Starvation_NNP for_IN host-derived_JJ L-_NNP tryptophan_NN ,_, which_WDT is_VBZ
          initiated_VBN by_IN induction_NN of_IN indoleamine_NN dioxygenase_NN by_IN
          IFN-γ_NNP ,_, undoubtedly_RB triggers_VBZ derepression_NN of_IN the_DT entire_JJ
          tryptophan_NN operon_NN ,_, including_VBG the_DT genes_NNS encoding_VBG PRPP_NNP
          synthase_NN and_CC kynureninase_NN ._. Kynureninase_NNP from_IN 
          C_NNP ._. psittaci_NN is_VBZ a_DT key_JJ linker_NN between_IN
          the_DT anthranilate-utilizing_JJ TrpB_NNP enzyme_NN that_IN initiates_NNS
          tryptophan_NN biosynthesis_NNS in_IN the_DT parasite_NN and_CC the_DT host_NN
          kynurenine_NN foramidase_NN that_WDT generates_VBZ kynurenine_NN ._. In_IN
          effect_NN a_DT hybrid_JJ host-parasite_JJ cycle_NN is_VBZ generated_VBN in_IN which_WDT
          a_DT metabolic_JJ stream_NN in_IN the_DT host_NN away_RB from_IN tryptophan_NN is_VBZ
          intercepted_VBN by_IN a_DT metabolic_JJ stream_NN toward_IN tryptophan_NN in_IN 
          C_NNP ._. psittaci_NN ._. 
          The_DT thoroughly_RB studied_VBN repressor_NN protein_NN that_WDT
          regulates_VBZ tryptophan_NN biosynthesis_NNS in_IN 
          E_NNP ._. coli_NNS is_VBZ of_IN limited_JJ phylogenetic_JJ
          distribution_NN ._. In_IN fact_NN ,_, 
          Xylella_NNP fastidiosa_NN ,_, C_NNP ._.
          trachomatis_NNS and_CC 
          C_NNP ._. psittaci_NN are_VBP the_DT only_JJ organisms_NNS
          outside_IN the_DT enteric_JJ lineage_NN known_VBN to_TO possess_VB 
          trpR_NN ._. The_DT GC_NNP content_NN of_IN 
          trpR_NN was_VBD examined_VBN for_IN evidence_NN of_IN
          possible_JJ horizontal_NN transfer_NN ._. Table_NNP 3_CD lists_NNS the_DT GC_NNP content_NN
          of_IN 
          trpR_NN genes_NNS ,_, compared_VBN to_TO the_DT GC_NNP
          content_NN of_IN the_DT corresponding_JJ genomes_NNS ._. The_DT 
          trpR_NN GC_NNP content_NN of_IN each_DT organism_NN
          corresponded_VBD relatively_RB well_RB to_TO the_DT genomic_JJ GC_NNP content_NN ,_,
          except_IN for_IN 
          X_NNP ._. fastidiosa_NN where_WRB 
          trpR_NN exhibited_VBN a_DT low_JJ GC_NNP content_NN ,_,
          more_RBR similar_JJ to_TO that_DT of_IN the_DT chlamydiae_NN or_CC 
          H_NNP ._. influenzae_NN ._. 
        
        
          Does_VBZ C_NNP ._. psittacihave_NN a_DT regulon_NN controlled_VBN by_IN
          trpR_NN ?_.
          In_IN 
          E_NNP ._. coli_NNS the_DT 
          trp_NN repressor_NN binds_NNS upstream_RB of_IN the_DT
          
          trp_NN operon_NN and_CC upstream_RB at_IN the_DT 
          mtr_NN transport_NN gene_NN in_IN promoter_NN
          regions_NNS where_WRB CTCG_NNP or_CC CTAG_NNP are_VBP important_JJ for_IN binding_JJ [_NN
          51_CD ]_NN ._. The_DT 
          sstT_NN gene_NN of_IN 
          E_NNP ._. coli_NNS is_VBZ also_RB subject_JJ to_TO
          repression_NN control_NN by_IN tryptophan_NN and_CC a_DT CTCG_NNP upstream_RB
          region_NN has_VBZ been_VBN proposed_VBN to_TO be_VB an_DT additional_JJ target_NN
          region_NN for_IN TrpR_NNP [_NN 49_CD ]_NN ._.
          As_IN 
          C_NNP ._. psittaci_NN has_VBZ 
          trpR_NN ,_, it_PRP seems_VBZ quite_RB possible_JJ that_IN
          the_DT 
          trp_NN operon_NN ,_, 
          sstT_NN (_( for_IN serine_NN transport_NN )_) ,_, and_CC 
          tyrP_NN (_( for_IN tryptophan_NN transport_NN )_)
          might_MD comprise_VB a_DT regulon_NN controlled_VBN by_IN the_DT 
          trpR_NN repressor_NN ._. Indeed_RB ,_, CTAG_NNP and_CC /_NN or_CC
          CTCG_NNP motifs_NNS were_VBD found_VBN upstream_RB of_IN all_PDT these_DT genes_NNS in_IN 
          C_NNP ._. psittaci_NN ,_, but_CC the_DT presence_NN of_IN
          these_DT regions_NNS did_VBD not_RB exceed_VB random_JJ probability_NN
          sufficiently_RB to_TO justify_VB any_DT concrete_JJ assertions_NNS ._. The_DT
          further_JJ use_NN of_IN a_DT computational_NN approach_NN [_NN 52_CD ]_NN to_TO identify_VB
          the_DT transcription_NN regulatory_JJ pattern_NN was_VBD also_RB not_RB
          illuminating_JJ ._. As_IN chlamydial_NN TrpR_NNP proteins_NNS are_VBP the_DT most_RBS
          divergent_JJ of_IN TrpR_NNP proteins_NNS ,_, the_DT motif_NN pattern_NN for_IN DNA_NNP
          binding_JJ may_MD also_RB be_VB divergent_JJ ._.
        
      
      
        Conclusions_NNP
        Chlamydial_NNP parasites_NNS appear_VBP to_TO respond_VB to_TO host_VB
        mechanisms_NNS for_IN restriction_NN of_IN tryptophan_NN availability_NN with_IN
        a_DT diversity_NN of_IN strategies_NNS ,_, the_DT exact_JJ nature_NN of_IN which_WDT we_PRP
        still_RB know_VBP very_RB little_JJ ._. One_CD strategy_NN utilized_JJ by_IN 
        C_NNP ._. muridarum_NN employs_VBZ a_DT three-copy_JJ
        dose_NN of_IN 
        lifA_NN ,_, which_WDT could_MD inhibit_VB cytokine_NN
        proliferation_NN and_CC decrease_VB IFN-γ_NNP production_NN by_IN the_DT host_NN
        (_( although_IN at_IN least_JJS some_DT IFN-γ_NNP has_VBZ been_VBN shown_VBN to_TO be_VB produced_VBN
        in_IN mice_NNS infected_VBN with_IN 
        C_NNP ._. muridarum_NN [_NN 53_CD ]_NN )_) ._. Such_JJ a_DT strategy_NN
        would_MD seem_VB to_TO be_VB consistent_JJ with_IN acute_JJ infections_NNS ,_, which_WDT
        can_MD be_VB a_DT successful_JJ mode_NN of_IN pathogenicity_NN in_IN some_DT
        situations_NNS ,_, such_JJ as_IN high-density_JJ rodent_NN populations_NNS ._. In_IN the_DT
        case_NN of_IN 
        C_NNP ._. muridarum_NN ,_, the_DT mechanism_NN does_VBZ not_RB
        necessarily_RB involve_VB blocking_VBG the_DT induction_NN of_IN indoleamine_NN
        dioxygenase_NN and_CC thereby_RB preventing_VBG depletion_NN of_IN host_NN
        tryptophan_NN ,_, in_IN view_NN of_IN some_DT experimental_JJ work_NN with_IN the_DT
        MoPn_NNP /_NN mouse_NN model_NN system_NN ._. The_DT primary_JJ effect_NN of_IN the_DT IFN-γ_NNP
        may_MD not_RB be_VB to_TO cause_VB starvation_NN for_IN tryptophan_NN as_IN
        anti-chlamydial_JJ and_CC anti-proliferative_JJ activities_NNS of_IN murine_NN
        IFN-γ_NNP in_IN mouse_NN cells_NNS was_VBD not_RB reversible_JJ by_IN tryptophan_NN [_NN
        54_CD ]_NN ._. It_PRP has_VBZ been_VBN concluded_VBN in_IN other_JJ studies_NNS as_RB well_RB [_NN 55_CD ,_,
        56_CD ]_NN that_IN host-mediated_JJ tryptophan_NN depletion_NN is_VBZ not_RB an_DT
        important_JJ factor_NN in_IN the_DT MoPn_NNP /_NN mouse_NN model_NN system_NN ._. However_RB ,_, a_DT
        conflicting_JJ conclusion_NN was_VBD recently_RB published_VBN by_IN Perfettini_NNP
        
        et_CC al_NN ._. [_NN 57_CD ]_NN that_IN the_DT inhibitory_NN
        effect_NN of_IN IFN-γ_NNP in_IN mouse_NN cell_NN cultures_NNS and_CC genital_JJ tracts_NNS
        seems_VBZ to_TO be_VB due_JJ in_IN part_NN to_TO tryptophan_NN depletion_NN (_( because_IN
        inhibition_NN was_VBD partially_RB reversed_VBN by_IN tryptophan_NN )_) ._. It_PRP has_VBZ
        been_VBN generally_RB observed_VBN that_IN in_IN murine_NN systems_NNS indoleamine_NN
        dioxygenase_NN has_VBZ not_RB been_VBN induced_VBN by_IN IFN-γ_NNP under_IN the_DT same_JJ
        experimental_JJ conditions_NNS that_WDT readily_RB induce_VB synthesis_NN of_IN
        the_DT enzyme_NN in_IN human_JJ systems_NNS ._. However_RB ,_, the_DT potential_NN to_TO
        induce_VB the_DT dioxygenase_NN in_IN murine_NN systems_NNS by_IN IFN-γ_NNP exposure_NN
        has_VBZ been_VBN demonstrated_VBN when_WRB nitric_JJ oxide_NN production_NN is_VBZ
        blocked_VBN [_NN 41_CD ]_NN ._. Thus_RB ,_, it_PRP seems_VBZ that_IN the_DT key_JJ difference_NN
        between_IN the_DT mouse_NN and_CC human_JJ systems_NNS might_MD lie_VB in_IN the_DT
        details_NNS that_WDT dictate_VBP the_DT balance_NN between_IN the_DT
        cross-regulated_JJ pathways_NNS of_IN tryptophan_NN and_CC arginine_NN
        metabolism_NN (_( see_VB Figure_NN 2_LS )_) ._. If_IN so_RB ,_, in_IN human_JJ systems_NNS the_DT
        balance_NN favors_VBZ domination_NN by_IN the_DT indoleamine_NN dioxygenase_NN
        route_NN ,_, whereas_IN in_IN murine_NN systems_NNS the_DT nitric_JJ oxide_NN route_NN is_VBZ
        favored_VBN ._. Many_JJ individual_JJ factors_NNS could_MD influence_VB the_DT
        balance_NN ,_, including_VBG differential_NN sensitivities_NNS of_IN NO_DT
        synthase_NN to_TO inhibition_NN by_IN 3_CD -_: hydroxyanthranilate_NN or_CC of_IN
        indoleamine_NN dioxygenase_NN to_TO inhibition_NN by_IN nitric_JJ oxide_NN ._. In_IN
        addition_NN ,_, unidentified_JJ cytokine-mediated_JJ mechanisms_NNS
        undoubtedly_RB await_VBP elucidation_NN ._.
        In_IN any_DT event_NN ,_, for_IN most_JJS chlamydiae_NN the_DT successful_JJ
        implementation_NN of_IN tryptophan_NN depletion_NN by_IN the_DT host_NN is_VBZ
        closely_RB tied_VBN to_TO chlamydial_NN responses_NNS that_WDT result_NN in_IN a_DT
        persistent_JJ metabolic_JJ state_NN and_CC chronic_JJ disease_NN ._. It_PRP would_MD
        appear_VB that_DT chlamydiae_NN have_VBP learned_VBN to_TO recognize_VB and_CC
        exploit_VB tryptophan_NN depletion_NN as_IN an_DT environmental_JJ cue_NN that_IN
        initiates_NNS a_DT distinct_JJ chain_NN of_IN remodeling_VBG biochemistry_NN that_WDT
        promotes_VBZ long-term_JJ viability_NN in_IN a_DT latent_NN state_NN ._.
        It_PRP is_VBZ difficult_JJ to_TO guess_VB whether_IN the_DT ability_NN of_IN 
        C_NNP ._. psittaci_NN to_TO scavenge_NN kynurenine_NN as_IN
        a_DT source_NN of_IN tryptophan_NN is_VBZ a_DT recent_JJ innovation_NN in_IN this_DT
        lineage_NN ,_, or_CC whether_IN it_PRP represents_VBZ an_DT ancient_JJ chlamydial_NN
        strategy_NN that_WDT has_VBZ been_VBN abandoned_VBN by_IN other_JJ chlamydiae_NN ._.
        Perhaps_RB the_DT strategy_NN is_VBZ linked_VBN to_TO the_DT particular_JJ tissue_NN
        tropism_NN of_IN 
        C_NNP ._. psittaci_NN ._. Because_IN the_DT presence_NN of_IN
        the_DT tryptophan-pathway_JJ enzymes_NNS varies_VBZ so_RB markedly_RB ,_, even_RB
        between_IN closely_RB related_VBN stains_NNS ,_, one_CD cannot_NN be_VB certain_JJ at_IN
        this_DT point_NN that_IN the_DT tryptophan-recapture_JJ cycle_NN is_VBZ uniquely_RB
        characteristic_NN of_IN 
        C_NNP ._. psittaci_NN ._. It_PRP cannot_NN be_VB ruled_VBN out_RP
        that_IN other_JJ strains_NNS of_IN 
        C_NNP ._. psittaci_NN might_MD lack_NN the_DT cycle_NN ,_,
        whereas_IN some_DT strains_NNS of_IN 
        C_NNP ._. trachomatis_NNS or_CC 
        C_NNP ._. pneumoniae_NN not_RB yet_RB sequenced_JJ might_MD
        possess_VB it_PRP ._. Different_JJ overall_JJ host_NN metabolism_NN and_CC different_JJ
        biochemical_JJ environments_NNS in_IN various_JJ tissues_NNS undoubtedly_RB
        influence_VBP the_DT availability_NN of_IN kynurenine_NN (_( as_RB well_RB as_IN other_JJ
        metabolites_NNS such_JJ as_IN ATP_NNP and_CC serine_NN )_) ._. Hence_RB ,_, tissue_NN tropism_NN
        must_MD be_VB a_DT crucial_JJ factor_NN ._. It_PRP would_MD be_VB interesting_JJ to_TO know_VB
        whether_IN the_DT tryptophan-recapture_JJ cycle_NN is_VBZ capable_JJ of_IN
        providing_VBG abundant_JJ tryptophan_NN to_TO the_DT parasite_NN ,_, or_CC whether_IN
        it_PRP might_MD be_VB more_RBR subtly_RB geared_VBN to_TO provision_NN of_IN barely_RB
        adequate_JJ tryptophan_NN for_IN parasites_NNS established_VBN in_IN the_DT
        chronic-infection_JJ mode_NN ._.
      
    
  
